Simplex Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-264
| Closed | -$2K | – | 10262 |
|
|
2023
Q1 | $2K | Sell |
264
-1,573
| -86% | -$20.9K | ﹤0.01% | 8588 |
|
|
2022
Q4 | $21K | Buy |
1,837
+28
| +2% | +$320 | ﹤0.01% | 6851 |
|
|
2022
Q3 | $25K | Sell |
1,809
-681
| -27% | -$17.6K | ﹤0.01% | 7298 |
|
|
2022
Q2 | $87K | Sell |
2,490
-801
| -24% | -$25K | ﹤0.01% | 5766 |
|
|
2022
Q1 | $131K | Buy |
3,291
+911
| +38% | +$39.1K | ﹤0.01% | 5772 |
|
|
2021
Q4 | $100K | Sell |
2,380
-753
| -24% | -$47K | ﹤0.01% | 6255 |
|
|
2021
Q3 | $245K | Buy |
3,133
+4
| +0.1% | +$293 | ﹤0.01% | 5271 |
|
|
2021
Q2 | $240K | Buy |
3,129
+3,111
| +17,283% | +$189K | ﹤0.01% | 5384 |
|
|
2021
Q1 | $120K | Sell |
18
-5
| -22% | -$389 | ﹤0.01% | 5486 |
|
|
2020
Q4 | $79K | Buy |
23
+2
| +10% | +$89 | ﹤0.01% | 5680 |
|
|
2020
Q3 | $116K | Buy |
+21
| New | +$1.24K | ﹤0.01% | 4738 |
|
|
2020
Q2 | – | Sell |
-16
| Closed | -$38K | – | 8580 |
|
|
2020
Q1 | $38K | Sell |
16
-18
| -53% | -$764 | ﹤0.01% | 5433 |
|
|
2019
Q4 | $168K | Buy |
+34
| New | +$1.65K | ﹤0.01% | 3944 |
|
|
2019
Q3 | – | Sell |
-4
| Closed | -$31K | – | 8061 |
|
|
2019
Q2 | $31K | Buy |
4
+2
| +100% | +$243 | ﹤0.01% | 5250 |
|
|
2019
Q1 | $33K | Sell |
2
-10
| -83% | -$1.93K | ﹤0.01% | 5343 |
|
|
2018
Q4 | $196K | Buy |
12
+9
| +300% | +$1.72K | ﹤0.01% | 3185 |
|
|
2018
Q3 | $85K | Sell |
3
-5
| -63% | -$1.18K | ﹤0.01% | 4601 |
|
|
2018
Q2 | $173K | Buy |
+8
| New | +$2.14K | ﹤0.01% | 3661 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$12K | – | 6882 |
|
|
2017
Q3 | $12K | Sell |
2
-9
| -82% | -$3.19K | ﹤0.01% | 3633 |
|
|
2017
Q2 | $40K | Buy |
11
+10
| +1,000% | +$3K | ﹤0.01% | 2600 |
|
|
2017
Q1 | $18K | Sell |
1
-4
| -80% | -$1.01K | ﹤0.01% | 3375 |
|
|
2016
Q4 | $7K | Sell |
5
-4
| -44% | -$802 | ﹤0.01% | 4107 |
|
|
2016
Q3 | $15K | Buy |
9
+4
| +80% | +$831 | ﹤0.01% | 3278 |
|
|
2016
Q2 | $13K | Buy |
+5
| New | +$2.3K | ﹤0.01% | 3363 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$2K | – | 6422 |
|
|
2015
Q4 | $2K | Buy |
+1
| New | +$313 | ﹤0.01% | 4638 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$9K | – | 6350 |
|
|
2015
Q2 | $9K | Buy |
+1
| New | +$302 | ﹤0.01% | 3185 |
|
Other funds holding DMK
Simplex Trading's DMK Position: Q2 2023 in Review
Simplex Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 128 shares — an estimated $1K sold.
Simplex Trading first reported a position in DMK in Q1 2015 and held it in 14 quarters. The position peaked at $133K in Q3 2017. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.
- Simplex Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 128 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $1K.
- Simplex Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and held it in 14 quarters.
- Simplex Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $133K in Q3 2017.
- 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.